Design, synthesis and structure-activity relationships of novel strychnine-insensitive glycine receptor ligands

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 10, 1999, Pages 1409-1414

  Cordi, A ^a   Lacoste, J M ^a   Audinot, V ^b   Millan, M ^b  

^a INSTITUT DE RECHERCHES SERVIER   (France)

^b INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINO 1 HYDROXY 4 METHYL 2 PYRROLIDINONE; 3 HYDROXYIMIDAZOLIDIN 4 ONE; CYCLOSERINE; DIZOCILPINE; GLYCINE; GLYCINE RECEPTOR AGONIST; IMIDAZOLIDINONE DERIVATIVE; LIGAND; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; STRYCHNINE; UNCLASSIFIED DRUG;

ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DRUG DESIGN; DRUG POTENCY; DRUG SYNTHESIS; EPILEPSY; IN VITRO STUDY; PAIN; RECEPTOR AFFINITY; SCHIZOPHRENIA; STROKE; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; X RAY DIFFRACTION;

DRUG DESIGN; GLYCINE; IMIDAZOLES; LIGANDS; RECEPTORS, N-METHYL-D-ASPARTATE; STRUCTURE-ACTIVITY RELATIONSHIP; STRYCHNINE;

EID: 0033577770     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00194-8     Document Type: Article

References (22)

1. Johnson, J.W.; Asher P. Nature 1987, 325, 529-531.
2. Leeson P.D.; Iversen L.L. J. Med. Chem. 1994, 37, 4053-4067.
3. Monahan J.B.; Handelman G.E.; Hood W.F.; Cordi A.A. Pharmacol. Biochem. & Behav. 1989, 34, 649-653.
4. Smith S.E.; Meldrum B.S. Eur. J. Pharmacol. 1992, 211, 109-111.
5. Waziri R. Biol. Psychiatry 1988, 23, 210-211.
6. Millan M.J.; Seguin L. Eur. J. Pharmacol. 1993, 238, 445-447.
7. Nowak G.; Trullas R.; Layer R.T.; Skolnick P.; Paul I.A. J. Pharmacol Exp. Ther. 1993, 265, 1380-1386.
8. Von Lubitz D.K.J.E.; Lin R.C.-S.; McKenzie R.J.; Devlin T.M.; McCabe R.T.; Skolnick P. Eur. J. Pharmacol. 1992, 219, 153-158.
9. Marvizon J.-L.; Lewin A.H.; Skolnick P. J. Neurochem. 1989, 52, 992-994.
10. Hood W.F.; Compton R.P.; Monahan J.B. Neurosci. Lett. 1989, 98, 91-95.
11. Leeson P.D.; Williams B.J.; Ladduwahetty T.; Moore K.W.; Rowley M. J. Chem. Soc. Chem. Comm. 1990, 1578-1580.
12. Leeson P.D.; Williams B.J.; Rowley M.; Moore K.W.; Baker R.; Kemp J.A.; Foster A.C.; Donald A.E. Bioorg. Med. Chem. Lett. 1993, 3, 71-76.
13. Harmon R.E.; Rizzo V.L.; Gupta S.K. J. Heterocyclic Chem. 1970, 7, 439-442.
14. + = 102.0425 (calc.: 102.0429).
15. Satsumabayashi S.; Moboki S.; Muratra K.; Takahashi A. Synthesis 1977, 881-883.
16. Robert J.M.; Gomer J.D.EP 0409617 A2 to ICI 1990.
17. Pfeiffer U.; Riccaboni M.T.; Erba R.; Pinta M. Liebigs Ann. Chem. 1988, 993-995.
18. Frankel M.; Knobler Y.; Bonni E.; Bittner S.; Zvilichovsky G. J. Chem. Soc. (C) 1969, 1746-1749.
19. Stammer C.H.; Wilson A.E.; Spencer C.F.; Bachelor F.W.; Holly F.W.; Folkers K. J. Am. Chem. Soc. 1957, 79, 3236-3240.
20. Baganz H.; Dransch G. Chem. Berichte 1960, 93, 784-791.
21. Monahan J.B.; Corpus V.M.; Hood W.F.; Thomas J.W.; Compton R.P. J. Neurochem. 1989, 53, 370-375.
22. 3H]-MK 801 binding.